Applications of (S)-3-Hydroxy-Gamma-Butyrolactone in Industrial Manufacturing

As a dedicated chemical raw material manufacturer, we supply (S)-3-Hydroxy-Gamma-Butyrolactone for advanced applications across several highly specialized downstream industries. Below, we detail specific usage scenarios where this chiral intermediate plays a critical role in formulation, process integration, and the end-product performance required by regulatory and market demands.

1. Chiral Pharmaceutical Synthesis: Active Pharmaceutical Ingredients (APIs)

Specialty pharma manufacturers consistently rely on (S)-3-Hydroxy-Gamma-Butyrolactone as a primary chiral building block when developing enantiomerically pure APIs such as antiviral drugs, CNS active agents, and advanced β-lactam antibiotics. Its stereochemical integrity directly affects the pharmacological activity and regulatory acceptability of the resulting API. Our material enters enantioselective synthesis protocols, ensuring critical stereopurity throughout multi-step synthesis, especially during nucleophilic ring opening and subsequent transformation steps.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP, EP, JP monograph specifications (where applicable for finished APIs)
• 21 CFR Parts 210/211 for pharmaceutical manufacturing
• FDA DMF (Drug Master File) referencing for regulated markets

Typical usage ratio

• 0.15–1.2 molar equivalents, depending on target molecule, with adjustment based on yield and impurity profile control in scale-up synthesis

Downstream process integration

• Input as a key intermediate during stereoselective condensation or reductive amination under controlled temperature and chiral catalyst systems
• Monitored via chiral HPLC analysis at the intermediate and final API stages for enantiomeric excess

Final product types

• Enantiomerically pure CNS drugs (e.g., GABA analogues)
• Targeted antiviral agents
• Chiral β-lactam antibiotics
• Precursor for optically active pyrrolidones

2. Agrochemical Intermediates: Stereospecific Pesticide Synthesis

Producers of high-value agrochemicals utilize (S)-3-Hydroxy-Gamma-Butyrolactone within the stereochemical route towards certain selective herbicides and insecticides, where only the (S)-enantiomer exhibits desired biological activity. Input at the early ring-opening stage leads to downstream products where chiral purity dictates field efficacy and regulatory approval for crop protection agents.

Industry compliance standards

• REACH (EC/1907/2006) for chemical substance registration
• ISO 9001:2015 for agrochemical manufacturing QMS
• FAO/WHO Specifications (JMPS/AGP/1999/1) for pesticide quality and purity
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• 0.8–1.0 mole equivalent relative to core substrate in chiral pesticide synthesis; precisely tied to the intended molecular target and reaction pathway efficiency

Downstream process integration

• Direct application in the synthesis of gamma-lactone-containing pesticide intermediates; typically enters during chiral ring opening and functionalization step
• Chiral LC and GC monitoring throughout the process for unwanted isomer formation

Final product types

• S-enantiomer herbicide intermediates
• Selective insecticide precursors
• Chiral cyclopropane carboxylate intermediates

3. Synthesis of Chiral Flavor & Fragrance Ingredients

Leading flavor and fragrance manufacturers integrate (S)-3-Hydroxy-Gamma-Butyrolactone as a source for optically pure lactone and gamma-hydroxy acid notes, which impart nuanced taste and olfactory profiles in premium end products. The organoleptic output directly depends on the enantiomeric purity of intermediate lactones, making our material critical during the production of natural and nature-identical flavorings.

Industry compliance standards

• FEMA GRAS status for food additives
• IFRA Code of Practice for fragrance material safety
• EU Regulation (EC) No 1334/2008 on flavorings and certain food ingredients
• ISO 9001:2015 QMS for food and fragrance production

Typical usage ratio

• 0.05–0.30% w/w for specialty flavor blends and fragrance bases; typically set according to desirable aroma intensity and legal maximum levels

Downstream process integration

• Enters as a chiral precursor in lactone or hydroxy acid synthesis before esterification or cyclization steps
• Subject to GC-MS and chiral analysis throughout process verification to exclude non-permitted isomers

Final product types

• Chiral delta- and gamma-lactone aroma chemicals
• (S)-hydroxy acid-based flavor ingredients
• Fine fragrance accords and specialty olfactory notes

4. Fine Chemical Synthesis: Chiral Auxiliary and Research Chemicals

Research-driven fine chemical companies use (S)-3-Hydroxy-Gamma-Butyrolactone as a key chiral auxiliary for asymmetric synthesis in organic chemistry laboratories and pilot-scale process development. Its configuration enables catalytic transformations and derivatizations that underpin high-throughput methods for new molecule discovery and specialty compound production.

Industry compliance standards

• ISO 17034:2016 for reference material producers
• OECD Good Laboratory Practice Guidelines
• Applicable local EHS chemical handling regulations
• Customer-specific QC acceptance criteria

Typical usage ratio

• 0.3–1.0 molar equivalent, depending on the complexity of the asymmetric synthesis; scalable for batch or flow chemistry platforms as required by experimental design

Downstream process integration

• Introduced as a chiral starting material or auxiliary in enantioselective formation of heterocycles, amino alcohols, and polyols
• Monitored by NMR and chiral chromatography at each stage for structural confirmation and purity assessment

Final product types

• Chiral research compounds
• Enantioenriched heterocyclic intermediates
• Reference standards for analytical laboratories

5. Advanced Polymer Building Blocks: High-Performance Materials

Materials science firms advancing chiral polymer and specialty plastics technology incorporate (S)-3-Hydroxy-Gamma-Butyrolactone as a precise monomer for customized polymer chain assembly. Its controlled stereochemistry translates into polymers with distinct mechanical, optical, or degradability behaviors, supporting innovation in smart packaging and bioengineering devices.

Industry compliance standards

• ISO 10993 biocompatibility (for medical-use polymers)
• EN 13432 for compostable plastics (where applicable)
• REACH and RoHS conformity for industrial material safety
• Customer-specified polymer QC benchmarks

Typical usage ratio

• 2–8% molar loading in copolymerization reactions; exact proportion determined by desired crystallinity, chirality balance, and final material specifications

Downstream process integration

• Added as a functional co-monomer during melt-state or solution-phase polymerization
• Stereochemical integrity validated by DSC and chiral GPC during QA/QC

Final product types

• Chiral polyesters and polyamides
• High-performance biodegradable plastics
• Functionalized polymers for biomedical engineering